SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on March 30, 2004. The report serves to announce the company's consolidated financial results for the third quarter ended February 29, 2004. The filing incorporates a press release (Exhibit 99.1) containing the detailed results.
Key Financial Metrics
The provided filing text acts as a cover document and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the issuance of results for the third quarter ended February 29, 2004.
Guidance, Outlook, and Risks
The document does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information in the Form 8-K and Exhibit 99.1 should not be deemed "filed" for purposes of the Securities Exchange Act of 1934 nor incorporated by reference into other filings.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the attached press release (Exhibit 99.1) as they are not listed in the main filing text.
- Confirm the company name discrepancy: The input metadata lists "LIFECORE BIOMEDICAL, INC.", but the filing is explicitly for "LANDEC CORPORATION".
- Review the full text of Exhibit 99.1 for any material changes, guidance, or risk factors omitted from this summary.
- Note that the financial results in this filing are not deemed "filed" under the Securities Exchange Act of 1934.